Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 76.67K 72.07K 65.89K 123K 8.37M 124K 866K 336K 4.27M 328K 321K 13.83M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 216M 203M 185M 346M 23.54B 349M 2.44B 944M 12B 923M 903M 38.91B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+3.65%+3.22%+60.34%+115.38% 1,026B
+1.30%+1.09%+54.60%+70.44% 649B
+0.46%+0.54%+20.67%+71.65% 468B
+0.48%+0.94%+40.28%+46.10% 352B
+1.48%+2.79%+21.91%+28.93% 271B
+0.28%+0.11%+10.99%+11.15% 256B
+0.32%+7.04%+45.59%+52.33% 220B
+0.65%+0.62%+33.57%+102.89% 188B
+0.44%-9.49%-31.95%-60.32% 170B
Average +0.91%+1.13%+28.44%+48.73% 359.91B
Weighted average by Cap. +1.60%+1.26%+39.13%+68.10%

Financials

2016 2017
Net sales 54.27M 47.63M 44.77M 40.94M 76.5M 5.2B 77.06M 538M 208M 2.65B 204M 199M 8.59B 106M 92.99M 87.41M 79.92M 149M 10.15B 150M 1.05B 407M 5.17B 398M 389M 16.78B
Net income -103M -90.38M -84.96M -77.68M -145M -9.86B -146M -1.02B -396M -5.03B -387M -378M -16.31B -125M -110M -103M -94.44M -176M -11.99B -178M -1.24B -481M -6.11B -470M -460M -19.83B
Net Debt 209M 184M 173M 158M 295M 20.07B 297M 2.08B 805M 10.23B 787M 769M 33.17B 246M 216M 203M 185M 346M 23.53B 349M 2.43B 944M 12B 923M 902M 38.9B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock